Toujeo Solostar (insulin glargine) is a form of insulin for the treatment of hypoglycemia (diabetes) in people from the age of six and upwards. Toujeo Solostar pens are loaded with 450 units of insulin glargine, a long-acting synthetic version of human insulin that keeps blood sugar levels steady throughout the day.
Dosage
Toujeo Solostar is a preloaded pen that can deliver up to 80 units of insulin per injection. The dosage (number of units per injection) must be determined by the prescribing doctor. Doses can be set from 1 to 80 units in steps of 1 unit and viewed in the clear window on the pen.
Storage
Store in the refrigerator at 2°C – 8°C (38°F – 48°F). Once opened, the Toujeo SoloStar pen must be kept out of the refrigerator but not at temperatures higher than 30°C (86°F). It can be used for up to 6 weeks after opening, then carefully disposed of.
Please read our friendly tips on handling medicine safely.
Read the information leaflet that comes with the medication.
Most people who use Toujeo SoloStart do not experience any negative side effects. Doctors prescribe Toujeo because they assess that the benefits of such treatment outweigh any likely unwanted effects.
Some of the side effects that have been reported include:
- Hypoglycemia (low blood sugar) – more likely in children with type 1 diabetes and can be more severe
- Skin thickening, lumps, or dents at an injection site
- Flu-like symptoms (upper respiratory tract infections)
- Injection site reaction
- Weight gain
- Peripheral edema (swelling in the feet, ankles, or legs)
- Joint pain
- Weight gain
- Diarrhea
Not all side effects are listed here. If these or other unlisted symptoms persist or worsen, consult a healthcare provider or pharmacist.
People from the age of six and adults who have been diagnosed with diabetes (hypoglycemia) require additional insulin to control their blood sugar levels. High blood sugar is a potentially serious or even fatal condition and needs to be treated and monitored constantly.
Diabetes is diagnosed by employing laboratory analysis of blood and urine samples. Type 1 diabetes blood samples contain remnants of antibodies that attack the pancreas, the site of insulin production. Type 2 diabetics have high sugar content in the urine or blood.